SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis

Loss of SPRY2 and activation of receptor tyrosine kinases are common events in prostate cancer (PC). However, the molecular basis of their interaction and clinical impact remains to be fully examined. SPRY2 loss may functionally synergize with aberrant cellular signalling to drive PC and to promote...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Meiling, Patel, Rachana, Ahmad, Imran, Fleming, Janis, Edwards, Joanne, McCracken, Stuart, Sahadevan, Kanagasabai, Seywright, Morag, Norman, Jim, Sansom, Owen, Leung, Hing Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: WILEY-VCH Verlag 2012
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494076/
https://www.ncbi.nlm.nih.gov/pubmed/22649008
http://dx.doi.org/10.1002/emmm.201100944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494076/
https://www.ncbi.nlm.nih.gov/pubmed/22649008
http://dx.doi.org/10.1002/emmm.201100944

Ejemplares similares